187 related articles for article (PubMed ID: 8605355)
1. Plasma cells induce apoptosis of pre-B cells by interacting with bone marrow stromal cells.
Tsujimoto T; Lisukov IA; Huang N; Mahmoud MS; Kawano MM
Blood; 1996 Apr; 87(8):3375-83. PubMed ID: 8605355
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of early plasma cells on bone marrow stromal cells requires interleukin-6 for escaping from apoptosis.
Kawano MM; Mihara K; Huang N; Tsujimoto T; Kuramoto A
Blood; 1995 Jan; 85(2):487-94. PubMed ID: 7812003
[TBL] [Abstract][Full Text] [Related]
3. Tumor-specific aneuploidy not detected in CD19+ B-lymphoid cells from myeloma patients in a multidimensional flow cytometric analysis.
McSweeney PA; Wells DA; Shults KE; Nash RA; Bensinger WI; Buckner CD; Loken MR
Blood; 1996 Jul; 88(2):622-32. PubMed ID: 8695810
[TBL] [Abstract][Full Text] [Related]
4. Individual CD34+CD38lowCD19-CD10- progenitor cells from human cord blood generate B lymphocytes and granulocytes.
Berardi AC; Meffre E; Pflumio F; Katz A; Vainchenker W; Schiff C; Coulombel L
Blood; 1997 May; 89(10):3554-64. PubMed ID: 9160660
[TBL] [Abstract][Full Text] [Related]
5. TGF-beta and MIP-1 alpha exert their main inhibitory activity on very primitive CD34+2CD38- cells but show opposite effects on more mature CD34+CD38+ human hematopoietic progenitors.
Van Ranst PC; Snoeck HW; Lardon F; Lenjou M; Nijs G; Weekx SF; Rodrigus I; Berneman ZN; Van Bockstaele DR
Exp Hematol; 1996 Nov; 24(13):1509-15. PubMed ID: 8950234
[TBL] [Abstract][Full Text] [Related]
6. Leukemia inhibitory factor upregulates cytokine expression by a murine stromal cell line enabling the maintenance of highly enriched competitive repopulating stem cells.
Szilvassy SJ; Weller KP; Lin W; Sharma AK; Ho AS; Tsukamoto A; Hoffman R; Leiby KR; Gearing DP
Blood; 1996 Jun; 87(11):4618-28. PubMed ID: 8639830
[TBL] [Abstract][Full Text] [Related]
7. Senescent B lymphopoiesis is balanced in suppressive homeostasis: decrease in interleukin-7 and transforming growth factor-beta levels in stromal cells of senescence-accelerated mice.
Tsuboi I; Morimoto K; Hirabayashi Y; Li GX; Aizawa S; Mori KJ; Kanno J; Inoue T
Exp Biol Med (Maywood); 2004 Jun; 229(6):494-502. PubMed ID: 15169968
[TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of a human stroma-dependent myeloma cell line (MM5.1) and its stroma-independent variant (MM5.2).
Van Riet I; De Greef C; Aharchi F; Woischwill C; De Waele M; Bakkus M; Lacor P; Schots R; Van Camp B
Leukemia; 1997 Feb; 11(2):284-93. PubMed ID: 9009094
[TBL] [Abstract][Full Text] [Related]
9. In multiple myeloma, clonotypic B lymphocytes are detectable among CD19+ peripheral blood cells expressing CD38, CD56, and monotypic Ig light chain.
Bergsagel PL; Smith AM; Szczepek A; Mant MJ; Belch AR; Pilarski LM
Blood; 1995 Jan; 85(2):436-47. PubMed ID: 7529064
[TBL] [Abstract][Full Text] [Related]
10. Changes in the growth properties of CD34+, CD38- bone marrow progenitors during human fetal development.
Waller EK; Huang S; Terstappen L
Blood; 1995 Jul; 86(2):710-8. PubMed ID: 7541673
[TBL] [Abstract][Full Text] [Related]
11. The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell.
Billadeau D; Ahmann G; Greipp P; Van Ness B
J Exp Med; 1993 Sep; 178(3):1023-31. PubMed ID: 8350044
[TBL] [Abstract][Full Text] [Related]
12. Human pre-B cells differentiate into Ig-secreting plasma cells in the presence of interleukin-4 and activated CD4+ T cells or their membranes.
Punnonen J; Aversa G; de Vries JE
Blood; 1993 Nov; 82(9):2781-9. PubMed ID: 7693047
[TBL] [Abstract][Full Text] [Related]
13. Identification of early plasma cells in peripheral blood and their clinical significance.
Harada Y; Kawano MM; Huang N; Mahmoud MS; Lisukov IA; Mihara K; Tsujimoto T; Kuramoto A
Br J Haematol; 1996 Jan; 92(1):184-91. PubMed ID: 8562394
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric detection of aneuploid CD38(++) plasmacells and CD19(+) B-lymphocytes in bone marrow, peripheral blood and PBSC harvest in multiple myeloma patients.
Santonocito AM; Consoli U; Bagnato S; Milone G; Palumbo GA; Di Raimondo F; Stagno F; Guglielmo P; Giustolisi R
Leuk Res; 2004 May; 28(5):469-77. PubMed ID: 15068900
[TBL] [Abstract][Full Text] [Related]
15. Flt3 ligand induces proliferation of quiescent human bone marrow CD34+CD38- cells and maintains progenitor cells in vitro.
Shah AJ; Smogorzewska EM; Hannum C; Crooks GM
Blood; 1996 May; 87(9):3563-70. PubMed ID: 8611678
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.
Kara IO; Sahin B; Paydas S; Cetiner S
Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184
[TBL] [Abstract][Full Text] [Related]
17. Infection and replication of human cytomegalovirus in bone marrow stromal cells: effects on the production of IL-6, MIP-1alpha, and TGF-beta1.
Taichman RS; Nassiri MR; Reilly MJ; Ptak RG; Emerson SG; Drach JC
Bone Marrow Transplant; 1997 Mar; 19(5):471-80. PubMed ID: 9052914
[TBL] [Abstract][Full Text] [Related]
18. Peripheral blood CD34+ cells differ from bone marrow CD34+ cells in Thy-1 expression and cell cycle status in nonhuman primates mobilized or not mobilized with granulocyte colony-stimulating factor and/or stem cell factor.
Donahue RE; Kirby MR; Metzger ME; Agricola BA; Sellers SE; Cullis HM
Blood; 1996 Feb; 87(4):1644-53. PubMed ID: 8608259
[TBL] [Abstract][Full Text] [Related]
19. CD34+CD38dim cells in the human thymus can differentiate into T, natural killer, and dendritic cells but are distinct from pluripotent stem cells.
Res P; Martínez-Cáceres E; Cristina Jaleco A; Staal F; Noteboom E; Weijer K; Spits H
Blood; 1996 Jun; 87(12):5196-206. PubMed ID: 8652833
[TBL] [Abstract][Full Text] [Related]
20. Primary myeloma interaction and growth in coculture with healthy donor hematopoietic bone marrow.
Bam R; Khan S; Ling W; Randal SS; Li X; Barlogie B; Edmondson R; Yaccoby S
BMC Cancer; 2015 Nov; 15():864. PubMed ID: 26545722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
